双重载药多层海藻酸盐-壳聚糖缓释微球的制备及体外释放

doi:10.7503/cjcu20140992

摘要/Abstract

摘要：

采用滴注法将海藻酸钠与钙离子交联, 制成负载血管内皮生长因子(VEGF)的藻酸钙核心球, 利用层层自组装技术在核心球的表面依次包覆壳聚糖、海藻酸和壳聚糖, 壳聚糖中负载万古霉素(VAN), 形成多药载药缓控体系. 采用正交实验考察海藻酸钠浓度、钙离子浓度及壳聚糖浓度对VEGF和VAN的药物包封率和载药量的影响, 优化了制备工艺. 采用扫描电子显微镜观察多层微球的表面、截面形貌及粒径, 采用傅里叶变换红外光谱检测海藻酸盐与壳聚糖的自组装情况, 分别采用酶联免疫吸附(ELISA)双抗体夹心法和紫外分光光度法检测VEGF和VAN的包封率、载药量及体外释放情况. 结果表明, 海藻酸钠最优浓度为0.04 g/mL, 氯化钙最优浓度为0.15 g/mL, 壳聚糖最优浓度为0.01 g/mL. 微球光滑圆整, 均质实心, 直径900~1100 μm, VEGF的包封率达61.31%, VAN的包封率为3.48%. 体外释放实验结果表明, VEGF缓释时间为15.5 d, 并出现2个释放高峰; VAN缓释时间为4.5 d, 释药情况平稳持续, 无明显突释. 双重载药多层包覆微球兼具控制感染和促进血管生成两种潜能, 有望应用于组织工程骨的基础研究和临床实践.

关键词: 血管内皮生长因子, 万古霉素, 多层包覆微球, 药物缓释, 海藻酸, 壳聚糖

Abstract:

The core ball carrying vascular epithelial growth factor(VEGF) was first prepared by crosslinking of alginate and calcium. Then, chitosan, alginate, and chitosan again were coated on the surface of the core ball layer by layer using self-assembly technology, which constituted a multi-drug loaded release-controlled system at last, and vancomycin was loaded in the chitosan layer. The effect of the concentration of alginate, calcium and chitosan on microspheres’ morphology, size, drug loading and in vitro release was studied by an orthogonal experiment to find the best formula design. Morphologies of the surface and cross section and dia-meter were observed by scanning electron microscopy(SEM). Infrared absorption spectrum of the multilayer microspheres was also detected by Fourier transformed infrared spectrometer(FTIR). The result showed that the best concentrations of alginate, calcium and chitosan were 0.04, 0.15 and 0.01 g/mL, respectively. And in this case, the multilayer microspheres were typical spherical with smooth surface and the internal solid structure with a diameter ranging from 900 to 1100 μm. The entrapment efficiency of VEGF and vancomycin was 61.31% and 3.48%, respectively. In vitro, the release of VEGF could be sustained stably for up to 15.5 d with two releasing peak, which is surprising and exciting. As well, the release of vancomycin lasted for 4.5 d, which also meets the clinical needs. The research indicates that VEGF and vancomycin loaded multilayer microspheres possess good controlled release characteristics and have the potentials of controlling infection and promoting vascularization at the same time, which is hopeful for basic research and clinical application of tissue engineering bone(TEB).

Key words: Vascular epithelial growth factor, Vancomycin, Multilayer microspheres, Drug controlled release, Alginate, Chitosan

中图分类号:

O631

TrendMD:

杨军星, 王琦, 王媛媛, 韩舒, 姚佳伟, 邵思奇, 王敬龙, 刘志辉, 郭玉鹏. 双重载药多层海藻酸盐-壳聚糖缓释微球的制备及体外释放. 高等学校化学学报, 2015, 36(5): 1025.

YANG Junxing, WANG Qi, WANG Yuanyuan, HAN Shu, YAO Jiawei, SHAO Siqi, WANG Jinglong, LIU Zhihui, GUO Yupeng. Preparation and in vitro Release of Multilayer Alginate Chitosan Microspheres Loading VEGF and Vancomycin^†. Chem. J. Chinese Universities, 2015, 36(5): 1025.

图/表 8

参考文献 26

[1]	赵春华. 中国修复重建外科杂志, 2008, 22( 2), 129- 133
	Zhao C., H. , Chinese Journal of Reparative and Reconstructive Surgery, 2008, 22( 2), 129- 133
[2]	许建中. 第三军医大学学报, 2008, 30( 13), 1215- 1218
	Xu J., Z. , Acta Academiae Medicinae Militaris Tertiae, 2008, 30( 13), 1215- 1218
[3]	Hou T., Y. , Xu J., Z. , Li, Q. , Feng J., H. , Zen, L. , Tissue Eng. Part A, 2008, 14( 7), 1173- 1182
[4]	候天勇, 许建中, 李强, 罗飞. 中国矫形外科杂志, 2006, 14( 23), 1816- 1819
	Hou T., Y. , Xu J., Z. , Li, Q. , Luo, F. , Orthopedic Journal of China, 2006, 14( 23), 1816- 1819
[5]	Wu X., H. , Hou T., Y. , Luo, F. , Xing J., C. , He Q., Y. , Jin H., Y. , Xie, Z. , Xu J., Z. , Tissue Eng. Part A, 2013, 19( 21/22), 2486- 2494
[6]	候天勇, 许建中. 局解手术学杂志, 2014, 23( 4), 349- 452
	Hou T., Y. , Xu J., Z. , Journal of Regional Anatomy and Operative Surgery, 2014, 23( 4), 349- 452
[7]	Yu R., X. , Chen H., L. , Chen T., N. , Zhou X., Y. , Simul. Model Pract. Theory, 2008, 16( 1), 15- 25
[8]	Okuda, T. , Tominaga, K. , Kidoaki, S. , J. Control Release, 2010, 143( 2), 258- 264
[9]	Im J., S. , Lee S., K. , Bai B., C. , Lee Y., S. , J. Ind. Eng. Chem., 2012, 18( 1), 325- 330
[10]	王林, 李春燕, 何盼, 付丽, 周延民, 陈学思. 高等学校化学学报, 2011, 32( 7), 1622- 1628
	Wang, L. , Li C., Y. , He, P. , Fu, L. , Zhou Y., M. , Chen X., S. , Chem. J. Chinese Universities, 2011, 32( 7), 1622- 1628
[11]	林全愧, 计剑, 谭庆刚, 任科峰, 沈家骢. 高分子通报, 2006, (8), 58- 63
	Lin Q., K. , Ji J., Tan Q. G., Ren K. F., Shen J. C., Chinese Polymer Bulletin , 2006, (8), 58- 63
[12]	Borges, O. , Silva, M. , de Sousa, A. , Borchard, G. , Junginger H., E. , Cordeiro-da-Silva, A. , Int. Immunopharmacol, 2008, 8( 13/14), 1773- 1780
[13]	Glavas Dodov, M. , Calis, S. , Crcarevska M., S. , Geskovski, N. , Petrovska, V. , Goracinova, K. , Int. J. Pharm., 2009, 381( 2), 166- 175
[14]	Nagarwal R., C. , Kumar, R. , Pandit J., K. , Eur. J. Pharm. Sci., 2012, 47( 4), 678- 685
[15]	汪程, 汪令伟, 史晓宇, 由茂瑞, 许剑扬, 王林. 现代生物医学进展, 2014, 14( 16), 3174- 3176
	Wang, C. , Wang L., W. , Shi X., Y. , You M., R. , Xu J., Y. , Wang, L. , Progress in Modern Biomedicine, 2014, 14( 16), 3174- 3176
[16]	马树强, 彭建强, 李中檀, 李玉红, 巫伟东, 林奇生, 王坤正. 中国组织工程研究, 2012, 16( 25), 4663- 4666
	Ma S., Q. , Peng J., Q. , Li Z., T. , Li Y., H. , Wu W., D. , Lin Q., S. , Wang K., Z. , Chinese Journal of Tissue Engineering Research, 2012, 16( 25), 4663- 4666
[17]	何清义, 温立升, 李强, 许建中, 罗飞. 生物医学工程学杂志, 2007, 24( 6), 1301- 1304
	He Q., Y. , Wen L., S. , Li, Q. , Xu J., Z. , Luo, F. , Journal of Biomedical Engineering, 2007, 24( 6), 1301- 1304
[18]	南艳微, 郑晓玲. 中国药房, 2013, 24( 17), 1581- 1583
	Nan Y., W. , Zheng X., L. , China Pharmacy, 2013, 24( 17), 1581- 1583
[19]	杜青, 胡俊丽, 韩亚冬, 陈学思, 景遐斌. 高等学校化学学报, 2008, 29( 6), 1262- 1266
	Du, Q. , Hu J., L. , Han Y., D. , Chen X., S. , Jing X., B. , Chem. J. Chinese Universities, 2008, 29( 6), 1262- 1266
[20]	姜恒, 许建中, 候天勇. 成都医学院学报, 2011, 6( 2), 129- 132
	Jiang, H. , Xu J., Z. , Hou T., Y. , Journal of Chengdu Medical College, 2011, 6( 2), 129- 132
[21]	肖潮达, 周雪, 沈祥春, 肖海, 刘鲜林, 魏云鹏, 陶玲. 中国药房, 2014, 25( 45), 4275- 4278
	Xiao C., D. , Zhou, X. , Shen X., C. , Xiao, H. , Liu X., L. , Wei Y., P. , Tao, L. , China Pharmacy, 2014, 25( 45), 4275- 4278
[22]	刘国磊, 王帅, 王静, 曹雅培, 黄敬洪, 申磊, 曹德英. 中国药房, 2012, 23( 13), 1203- 1206
	Liu G., L. , Wang, S. , Wang, J. , Cao Y., P. , Huang J., H. , Shen, L. , Cao D., Y. , China Pharmacy, 2012, 23( 13), 1203- 1206
[23]	陈益清, 孙多先, 苏晶, 杨军. 高等学校化学学报, 2003, 24( 3), 481- 484
	Chen Y., Q. , Sun D., X. , Su, J. , Yang, J. , Chem. J. Chinese Universities, 2003, 24( 3), 481- 484
[24]	王政, 魏莉. 数理医药学杂志, 2014, 27( 1), 99- 102
	Wang, Z. , Wei, L. , Journal of Mathematical Medicine, 2014, 27( 1), 99- 102
[25]	王鑫众, 刘建国, 唐宇锋, 王宇, 章培标, 陈学思. 高等学校化学学报, 2013, 34( 4), 984- 991
	Wang X., Z. , Liu J., G. , Tang Y., F. , Wang, Y. , Zhang P., B. , Chen X., S. , Chem. J. Chinese Universities, 2013, 34( 4), 984- 991
[26]	王宏丽, 陈风雷, 陈涛, 胡雪梅, 李智, 辛莹. 西南大学学报(自然科学版), 2010, 32( 4), 469- 472
	Wang H., L. , Chen F., L. , Chen, T. , Hu X., M. , Li, Z. , Xin, Y. , Journal of Yunnan University(Natural Sciences Edition ), 2010, 32( 4), 469- 472

Group	Concentration of SA(A)/ (g·mL^-1)	Concentration of CaCl₂(B)/ (g·mL^-1)	Concentration of CS(C)/ (g·mL^-1)
1	0.04	0.05	0.03
2	0.01	0.15	0.02
3	0.04	0.15	0.01
4	0.01	0.10	0.03
5	0.02	0.15	0.03
6	0.04	0.10	0.02
7	0.02	0.05	0.02
8	0.02	0.10	0.01
9	0.01	0.05	0.01

Group	Concentration of SA(A)/ (g·mL^-1)	Concentration of CaCl₂(B)/ (g·mL^-1)	Concentration of CS(C)/ (g·mL^-1)
1	0.04	0.05	0.03
2	0.01	0.15	0.02
3	0.04	0.15	0.01
4	0.01	0.10	0.03
5	0.02	0.15	0.03
6	0.04	0.10	0.02
7	0.02	0.05	0.02
8	0.02	0.10	0.01
9	0.01	0.05	0.01

Group	Level			EE of VEGF(%)	EE of VAN(%)	DL of VEGF(%)	DL of VAN(%)
Group	A/(g·mL^-1)			EE of VEGF(%)	EE of VAN(%)	B/(g·mL^-1)	C/(g·mL^-1)
1	0.04	0.05	0.03	49.4	0.970	7.20×10^-5	0.532
2	0.01	0.15	0.02	27.7	2.53	1.23×10^-4	4.20
3	0.04	0.15	0.01	61.3	3.48	5.90×10^-5	1.25
4	0.01	0.10	0.03	46.9	2.55	1.77×10^-4	3.61
5	0.02	0.15	0.03	47.4	3.68	7.80×10^-5	2.26
6	0.04	0.10	0.02	55.2	0.850	6.10×10^-5	0.351
7	0.02	0.05	0.02	64.5	2.36	1.35×10^-4	1.86
8	0.02	0.10	0.01	39.6	4.17	7.10×10^-5	2.81
9	0.01	0.05	0.01	32.8	6.05	1.50×10^-4	10.4

Group	Level			EE of VEGF(%)	EE of VAN(%)	DL of VEGF(%)	DL of VAN(%)
Group	A/(g·mL^-1)			EE of VEGF(%)	EE of VAN(%)	B/(g·mL^-1)	C/(g·mL^-1)
1	0.04	0.05	0.03	49.4	0.970	7.20×10^-5	0.532
2	0.01	0.15	0.02	27.7	2.53	1.23×10^-4	4.20
3	0.04	0.15	0.01	61.3	3.48	5.90×10^-5	1.25
4	0.01	0.10	0.03	46.9	2.55	1.77×10^-4	3.61
5	0.02	0.15	0.03	47.4	3.68	7.80×10^-5	2.26
6	0.04	0.10	0.02	55.2	0.850	6.10×10^-5	0.351
7	0.02	0.05	0.02	64.5	2.36	1.35×10^-4	1.86
8	0.02	0.10	0.01	39.6	4.17	7.10×10^-5	2.81
9	0.01	0.05	0.01	32.8	6.05	1.50×10^-4	10.4

EE of VEGF(%)				EE of VAN(%)				DL of VEGF(%)				DL of VAN(%)
K1	K2	K3	R	K1	K2	K3	R	K1	K2	K3	R	K1	K2	K3	R
55.3	50.5	35.8	19.5	1.77	3.40	3.71	1.94	6.40×10^-5	9.50×10^-5	1.50×10^-4	8.60×10^-5	0.710	2.31	6.06	5.35
45.5	47.3	48.9	3.47	3.23	2.52	3.13	0.710	8.70×10^-5	1.03×10^-4	1.19×10^-4	0.320×10^-5	2.57	2.26	4.26	2.00
47.9	49.1	44.6	4.54	2.40	1.91	4.57	2.65	1.09×10^-4	1.06×10^-4	9.30×10^-5	1.70×10^-5	2.13	2.14	4.82	2.68